Thursday Feb 9 | Drugs.com
SEC Charges Former Pharmaceutical Company Employee with Insider Trading on Biotech Deals
WASHINGTON, Feb. 9, 2012 - The Securities and Exchange Commission today charged that a former employee of Takeda Pharmaceuticals International, Inc.
FDA Approves Subcutaneous Administration of VELCADEA In All Approved Indications
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved a supplemental new drug application for VELCADE , which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and ... (more)
Also on Topix